The pandemic challenged the global supply chain instantly. Geopolitical tensions and the call for localizations and self-reliance are further adding to the complexity of today’s API souring. In this article we look on supply chain security in a...
Read more ...

Cambrex eBook: The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021, driven by positive industry trends — many of which our experts commented on in Part 1 of the Cambrex eBook. Market data shows just how...
Read more ...

Cambrex experts have contributed more articles to our biggest eBook yet. The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities and employees than ever before. Enjoy Part 1 of our latest Cambrex...
Read more ...

To extract continuous value from R&D activities and ensure manufacturing quality, pharmaceutical companies are – or should be – embracing digital transformation. This business journey uses technology to turn fragmented systems into a harmonized...
Read more ...

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they needed a high quality, agile CDMO with...
Read more ...

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and safety. Discussion includes how current...
Read more ...